Filing Details

Accession Number:
0001179110-19-009616
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-19 16:34:06
Reporting Period:
2019-08-15
Accepted Time:
2019-08-19 16:34:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612528 Lonnel Coats C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-15 10,000 $15.01 10,000 No 4 M Direct
Common Stock Disposition 2019-08-15 2,702 $83.57 7,298 No 4 S Direct
Common Stock Disposition 2019-08-15 3,098 $82.48 4,200 No 4 S Direct
Common Stock Disposition 2019-08-15 4,200 $81.59 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-08-15 10,000 $0.00 10,000 $15.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,818 2026-02-03 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.97 to $83.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (3) to this Form 4.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.955 to $82.95 per share.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.19 to $81.94 per share.
  4. This option was granted on February 3, 2016. This option vested with respect to 1/36th of the shares underlying the option on March 3, 2016 and as to an additional 1/36th of the shares underlying the option each month thereafter.